Bernard J. Zovighian - 03 May 2024 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CEO, Director
Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
03 May 2024
Net transactions value
-$312,033
Form type
4
Filing time
07 May 2024, 17:53:27 UTC
Previous filing
01 Aug 2023
Next filing
09 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Tax liability $44,827 -527 -1.2% $85.06 44,289 03 May 2024 Direct
transaction EW Common Stock Options Exercise $0 +6,265 +14% $0.000000 50,554 04 May 2024 Direct F1
transaction EW Common Stock Tax liability $316,960 -3,718 -7.4% $85.25 46,836 04 May 2024 Direct
transaction EW Common Stock Purchase $49,753 +580 +22% $85.74 3,268 06 May 2024 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Performance Rights Options Exercise $0 -6,265 -100% $0.000000* 0 04 May 2024 Common Stock 6,265 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4.
F2 Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.